Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal CarcinomasLuis R. Lopez(Hospital Universitario Central de Asturias), Mario Hermsen(Gobierno del Principado de Asturias)Journal of Personalized MedicineOctober 18, 202310.3390/jpm13101504Cited by 5SaveCiteExport RISWatch citationsRelated PapersEGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma|Rhinology Journal|2020|34Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma|Cells|2023|5